[1]
Kutlu, Ömer, Karaarslan, E., Karaosmanoğlu, N. and Ekşioğlu, H.M. 2019. Evaluation of omalizumab at certain time intervals in patients with chronic spontaneous idiopathic urticaria. International Journal of Scientific Reports. 5, 12 (Nov. 2019), 351–354. DOI:https://doi.org/10.18203/issn.2454-2156.IntJSciRep20195299.